Klotho Financial Statements From 2010 to 2025
| KLTO Stock | 0.36 0.03 7.69% |
Check Klotho Neurosciences, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Klotho Neurosciences,'s main balance sheet or income statement drivers, such as , as well as many indicators such as . Klotho financial statements analysis is a perfect complement when working with Klotho Neurosciences, Valuation or Volatility modules.
Check out the analysis of Klotho Neurosciences, Correlation against competitors. Klotho Neurosciences, Company Return On Asset Analysis
Klotho Neurosciences,'s Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Klotho Neurosciences, Return On Asset | -0.72 |
Most of Klotho Neurosciences,'s fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Klotho Neurosciences, is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Klotho Neurosciences, has a Return On Asset of -0.7163. This is much lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The return on asset for all United States stocks is notably higher than that of the company.
Klotho Neurosciences, Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Klotho Neurosciences,'s current stock value. Our valuation model uses many indicators to compare Klotho Neurosciences, value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Klotho Neurosciences, competition to find correlations between indicators driving Klotho Neurosciences,'s intrinsic value. More Info.Klotho Neurosciences, is rated fifth overall in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Klotho Neurosciences,'s earnings, one of the primary drivers of an investment's value.About Klotho Neurosciences, Financial Statements
Klotho Neurosciences, investors utilize fundamental indicators, such as revenue or net income, to predict how Klotho Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Pair Trading with Klotho Neurosciences,
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Klotho Neurosciences, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Klotho Neurosciences, will appreciate offsetting losses from the drop in the long position's value.Moving together with Klotho Stock
Moving against Klotho Stock
| 0.68 | DNTH | Dianthus Therapeutics | PairCorr |
| 0.68 | DSGN | Design Therapeutics | PairCorr |
| 0.62 | 0P6S | Bayer AG NA | PairCorr |
| 0.58 | DMAC | DiaMedica Therapeutics | PairCorr |
| 0.58 | VCYT | Veracyte | PairCorr |
The ability to find closely correlated positions to Klotho Neurosciences, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Klotho Neurosciences, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Klotho Neurosciences, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Klotho Neurosciences, to buy it.
The correlation of Klotho Neurosciences, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Klotho Neurosciences, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Klotho Neurosciences, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Klotho Neurosciences, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Klotho Neurosciences, Correlation against competitors. To learn how to invest in Klotho Stock, please use our How to Invest in Klotho Neurosciences, guide.You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Klotho Neurosciences,. If investors know Klotho will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Klotho Neurosciences, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Klotho Neurosciences, is measured differently than its book value, which is the value of Klotho that is recorded on the company's balance sheet. Investors also form their own opinion of Klotho Neurosciences,'s value that differs from its market value or its book value, called intrinsic value, which is Klotho Neurosciences,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Klotho Neurosciences,'s market value can be influenced by many factors that don't directly affect Klotho Neurosciences,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Klotho Neurosciences,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Klotho Neurosciences, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Klotho Neurosciences,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.